Page 51 - profiles 2019 working copy containing all bios as of Feb 20 final version
P. 51

Award, Excellence in Emergency Response Deepwater Horizon Oil Spill

            Response Team; and the U.S. Pharmacopeia Group Award for an Innovative
            Response to Public Health Challenges. To better serve U.S. and Foreign
            Policy, I was appointed Member on the United Nations Food and Agriculture
            Organization/World Health Organization Joint Expert Committee on Food

            Additives. In addition, I currently serve as the Chair of the Maryland
            Federation (NARFE) Legislative Committee and on the Fulbright Association
            Board of Directors as Chair of the Advocacy Task Force.



            I am Dr. George J. Galasso, a Veteran, and I served in the National Institutes
            of Health (NIH), Department of Health and Human Services.  I graduated from

            Manhattan College in New York City, served in the U.S. Army, and
            subsequently earned a Ph.D. in Microbiology at the University of North
            Carolina.


            In 1968, I was accepted into the Grants Associates Program of the NIH, and
            began my career as an administrator of scientific programs.  I was
            subsequently hired by the National Institute of Allergy and Infectious Diseases

            (NIAID), where I initiated a contract program to investigate whether antiviral
            drugs could be found to treat virus infections. This was in the late 1960s when
            there was doubt that antivirals would be successful.  This program was able to
            demonstrate that antiviral agents could indeed be successfully used against

            ongoing serious viral infections.  The AIDS epidemic soon followed, with
            success in developing antivirals for treatment.  My efforts in the field of
            antiviral research, developing antivirals, including Interferon, for the treatment

            of viral infections and cancer, have been internationally recognized.

            I subsequently became Chief, Infectious Disease Branch, responsible for

            vaccine development in addition to antivirals.  In this capacity, I was
            responsible for the development of the Zoster vaccine and supported the
            development of pneumococcal vaccine.


            The second half of my career at NIH was as Associate Director for Extramural
            Affairs of the NIH, developing policies including conflict of interest
            guidelines, following Congressional authorization of government scientists to

            hold patents and collaborate with industry.  I have authored nearly 100
            scientific articles, reviews and two texts.  I am the recipient of numerous
            Public Health Service and Achievement Awards, as well as international

            awards and an Honorary Doctorate.


      47
   46   47   48   49   50   51   52   53   54   55   56